CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 71 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-17 | Jones James Director | Grant or award | +1,000 | $3.22 | $3K | 14,700 |
| 2021-03-17 | JACOBS JOEY A Director | Grant or award | +5,000 | $3.22 | $16K | 98,415 |
| 2021-03-17 | Griggs Jonathan Director | Grant or award | +1,000 | $3.22 | $3K | 14,803 |
| 2021-03-17 | Galante Joseph C Director | Grant or award | +1,000 | $3.22 | $3K | 32,417 |
| 2021-03-17 | Krogulski Kenneth Director | Grant or award | +1,000 | $3.22 | $3K | 167,495 |
| 2021-03-17 | KAZIMI A J Chairman and CEO | Shares withheld for taxes | −37,350 | $3.22 | $120K | 5,755,719 |
| 2021-03-17 | KAZIMI A J Chairman and CEO | Grant or award | +12,000 | $3.22 | $39K | 5,767,719 |
| 2021-03-17 | KAZIMI A J Chairman and CEO | Grant or award · Options (right to buy) | +88,000 | 88,000 | ||
| 2021-03-17 | Herman James L VP and Chief Compliance Office | Shares withheld for taxes | −2,560 | $3.22 | $8K | 45,001 |
| 2021-03-17 | Herman James L VP and Chief Compliance Office | Grant or award · Options (right to buy) | +3,000 | 3,000 | ||
| 2021-03-17 | Pavliv Leo SVP and Chief Development Off. | Shares withheld for taxes | −2,870 | $3.22 | $9K | 168,118 |
| 2021-03-17 | Pavliv Leo SVP and Chief Development Off. | Grant or award · Options (right to buy) | +5,000 | 5,000 | ||
| 2021-03-17 | Bonner Michael Chief Financial Officer | Shares withheld for taxes | −1,067 | $3.22 | $3K | 19,220 |
| 2021-03-17 | Bonner Michael Chief Financial Officer | Grant or award · Options (right to buy) | +5,000 | 5,000 | ||
| 2021-03-17 | Cearnal Martin E Sr VP/Chief Commercial Officer | Shares withheld for taxes | −2,945 | $3.22 | $9K | 148,814 |
| 2021-03-17 | Cearnal Martin E Sr VP/Chief Commercial Officer | Grant or award · Options (right to buy) | +5,000 | 5,000 | ||
| 2020-08-26 | Galante Joseph C Director | Purchase | +225 | $3.29 | $740 | 24,892 |
| 2020-08-21 | Galante Joseph C Director | Purchase | +375 | $3.35 | $1K | 24,667 |
| 2020-08-14 | Galante Joseph C Director | Purchase | +375 | $3.44 | $1K | 24,292 |
| 2020-08-07 | Galante Joseph C Director | Purchase | +375 | $3.42 | $1K | 23,917 |
Page 171 of 207 · 4,129 trades